FI861971A - Farmaceutiska kompositioner av pre-laekemedelstyp, foerfarande foer deras framstaellning, foerfarande foer framstaellning av de saosom pre-laekemedel verkande foereningarna, och haervid erhaollna foereningar. - Google Patents

Farmaceutiska kompositioner av pre-laekemedelstyp, foerfarande foer deras framstaellning, foerfarande foer framstaellning av de saosom pre-laekemedel verkande foereningarna, och haervid erhaollna foereningar. Download PDF

Info

Publication number
FI861971A
FI861971A FI861971A FI861971A FI861971A FI 861971 A FI861971 A FI 861971A FI 861971 A FI861971 A FI 861971A FI 861971 A FI861971 A FI 861971A FI 861971 A FI861971 A FI 861971A
Authority
FI
Finland
Prior art keywords
prodrug
foerfarande foer
framstaellning
pharmaceutical composition
laekemedelstyp
Prior art date
Application number
FI861971A
Other languages
English (en)
Finnish (fi)
Other versions
FI861971A0 (fi
Inventor
Frans Herwig Jan Jansen
Cock Etienne Jacquy De
Original Assignee
Ba Inpharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ba Inpharm Bv filed Critical Ba Inpharm Bv
Publication of FI861971A0 publication Critical patent/FI861971A0/fi
Publication of FI861971A publication Critical patent/FI861971A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/54Preparation of carboxylic acid anhydrides
    • C07C51/567Preparation of carboxylic acid anhydrides by reactions not involving carboxylic acid anhydride groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126Acids containing more than four carbon atoms
    • C07C53/128Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/02Saturated compounds containing hydroxy or O-metal groups
    • C07C62/06Saturated compounds containing hydroxy or O-metal groups polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI861971A 1985-05-15 1986-05-12 Farmaceutiska kompositioner av pre-laekemedelstyp, foerfarande foer deras framstaellning, foerfarande foer framstaellning av de saosom pre-laekemedel verkande foereningarna, och haervid erhaollna foereningar. FI861971A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8501408 1985-05-15

Publications (2)

Publication Number Publication Date
FI861971A0 FI861971A0 (fi) 1986-05-12
FI861971A true FI861971A (fi) 1986-11-16

Family

ID=19845998

Family Applications (1)

Application Number Title Priority Date Filing Date
FI861971A FI861971A (fi) 1985-05-15 1986-05-12 Farmaceutiska kompositioner av pre-laekemedelstyp, foerfarande foer deras framstaellning, foerfarande foer framstaellning av de saosom pre-laekemedel verkande foereningarna, och haervid erhaollna foereningar.

Country Status (10)

Country Link
US (1) US4863965A (no)
EP (1) EP0202703B1 (no)
JP (1) JPS61263916A (no)
AT (1) ATE45284T1 (no)
CA (1) CA1266828A (no)
DE (1) DE3664869D1 (no)
DK (1) DK225986A (no)
FI (1) FI861971A (no)
IL (1) IL80787A (no)
NO (1) NO861903L (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991009831A1 (en) * 1989-12-26 1991-07-11 Nova Pharmaceutical Corporation Prodrug anhydrides of asprin, indomethacin and ibuprofen, their preparation, compositions, and anti-inflammatory method of use
ES2096614T3 (es) * 1990-12-06 1997-03-16 Hoechst Ag Derivados de acidos biliares, procedimiento para su preparacion y utilizacion de este compuesto como medicamento.
CA2108041A1 (en) * 1991-03-29 1992-09-30 Nicholas S. Bodor Targeted drug delivery via mixed phosphate derivatives
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6090800A (en) * 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
EP1231209A1 (en) * 2000-12-19 2002-08-14 Specialized Pharmaceutical Research Ltd. Co. Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2577699A (en) * 1949-09-10 1951-12-04 Bristol Lab Inc Penicillin anhydrides
US3763152A (en) * 1968-09-16 1973-10-02 American Home Prod Neutral cephalosporin anhydrides
US4206220A (en) * 1978-07-13 1980-06-03 Interx Research Corporation Prodrugs for the improved delivery of non-steroidal anti-inflammatory agents

Also Published As

Publication number Publication date
EP0202703B1 (en) 1989-08-09
ATE45284T1 (de) 1989-08-15
IL80787A (en) 1991-08-16
FI861971A0 (fi) 1986-05-12
CA1266828A (en) 1990-03-20
NO861903L (no) 1986-11-17
JPS61263916A (ja) 1986-11-21
DE3664869D1 (en) 1989-09-14
US4863965A (en) 1989-09-05
EP0202703A1 (en) 1986-11-26
DK225986D0 (da) 1986-05-15
DK225986A (da) 1986-11-16

Similar Documents

Publication Publication Date Title
CA2003289A1 (en) Use of trifluoromethylphenyl-tetrahydropyridines for the preparation of pharmaceutical compositions useful for the treatment of anxiety and anxio-depressive disorders
IL97796A0 (en) Pharmaceutical compositions containing n-alkylated 1,4-dihydropyridine-dicarboxylic acid esters,certain such compounds and their preparation
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
EP0629400B1 (en) Idebenone compositions for treating Alzheimer's disease
FI861971A (fi) Farmaceutiska kompositioner av pre-laekemedelstyp, foerfarande foer deras framstaellning, foerfarande foer framstaellning av de saosom pre-laekemedel verkande foereningarna, och haervid erhaollna foereningar.
US3959470A (en) Psychotropic medicinal preparation
US4892876A (en) Method for inhibiting HIV and an pharmaceutical composition therefor
GB2030863A (en) Antibacterial compositions
US4436732A (en) Medicated compound for treating diseases infected by virus of the herpes group
FI58435C (fi) Foerfarande foer framstaellning av en intravenoesduglig sulfonamid och sulfonamidaktivator innehaollande vattenhaltig infusionloesning
EP0094412B1 (en) Medical process and preparation
US4189499A (en) Lysine 4-allyloxy-3-chlorophenylacetate and method of its preparation
US6528524B2 (en) Pharmaceutical compositions containing cinchonine dichlorhydrate
IE44419B1 (en) Analgesic composition
SE8800182L (sv) Anvaendning av alkylglycerol foer framstaellning av ett laekemedel
Riley The prodrug concept and new drug design and development
US4812482A (en) Application of α-[[(2-hydroxy-1, 1-dimethyl-ethyl) amine] methyl] benzene methanol hydrochloride (EL-508) as a drug with antiinflammatory action
US4661478A (en) Process for potentiating effects of barbituate anesthesia to a warm-blooded animal
JPS6358809B2 (no)
JPS61129126A (ja) 抗腫瘍剤
FR3108503A1 (fr) Composition pharmaceutique active contre une infection virale du type coronavirus
EP0101944B1 (en) Immunomodulators containing as the active ingredient alpha-benzyl malic acid
KR950700063A (ko) 외상후 스트레스 치료제로서의 브로파로민(Brofaromine as an agent for treating post-traumatic stress)
FR2728466A1 (fr) Utilisation d'un extrait de tripterygium wilfordii hook f et de ses composants pour le traitement du melanome cancereux
DE2711964A1 (de) Lysin-4-allyloxy-3-chlorphenylacetat, verfahren zu seiner herstellung und es enthaltende pharmazeutische zubereitung

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: B.V.B.A. INPHARM